Global Central Nervous System (CNS) Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 104

Published Date: 02 Jan 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Central Nervous System (CNS) Drug market size was valued at USD 119620 million in 2023 and is forecast to a readjusted size of USD 188330 million by 2030 with a CAGR of 6.7% during review period.

Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the ability to function. The condition may be an inherited metabolic disorder; the result of damage from an infection, a degenerative condition, stroke, a brain tumor or other problem; or arise from unknown or multiple factors. Movement disorders such as Parkinson’s disease, dystonia, and essential tremor are central nervous system conditions. What they have in common is the loss of sufficient, intact nervous system circuits that orchestrate functions as varied as memory formation (in Alzheimer’s) or voluntary motion (in movement disorders).

The presence of strong pipeline products is expected to drive the central nervous system therapeutics market over the forecast period. Major pharmaceutical companies are focusing on new treatments to prevent or improve symptoms of neurological diseases.

The Global Info Research report includes an overview of the development of the Central Nervous System (CNS) Drug industry chain, the market status of MS Therapeutics (Prescription Drugs, OTC), Antipsychotic Drugs (Prescription Drugs, OTC), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Central Nervous System (CNS) Drug.

Regionally, the report analyzes the Central Nervous System (CNS) Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Central Nervous System (CNS) Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Central Nervous System (CNS) Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Central Nervous System (CNS) Drug industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Prescription Drugs, OTC).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Central Nervous System (CNS) Drug market.

Regional Analysis: The report involves examining the Central Nervous System (CNS) Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Central Nervous System (CNS) Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Central Nervous System (CNS) Drug:
Company Analysis: Report covers individual Central Nervous System (CNS) Drug players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Central Nervous System (CNS) Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (MS Therapeutics, Antipsychotic Drugs).

Technology Analysis: Report covers specific technologies relevant to Central Nervous System (CNS) Drug. It assesses the current state, advancements, and potential future developments in Central Nervous System (CNS) Drug areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Central Nervous System (CNS) Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Central Nervous System (CNS) Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
Prescription Drugs
OTC

Market segment by Application
MS Therapeutics
Antipsychotic Drugs
Depression Drugs
Epilepsy Drugs
Others

Market segment by players, this report covers
Johnson & Johnson
Pfizer Inc
Novartis AG
GSK
Eli Lilly
Teva
Otsuka Pharmaceutical Co., Ltd
Biogen Inc
Boehringer Ingelheim
Roche
UCB
Tekeda
Shanghai Fosun
Jiangsu Nhwa Pharmaceutical Co., Ltd.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Central Nervous System (CNS) Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Central Nervous System (CNS) Drug, with revenue, gross margin and global market share of Central Nervous System (CNS) Drug from 2019 to 2024.
Chapter 3, the Central Nervous System (CNS) Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Central Nervous System (CNS) Drug market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Central Nervous System (CNS) Drug.
Chapter 13, to describe Central Nervous System (CNS) Drug research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Central Nervous System (CNS) Drug
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Central Nervous System (CNS) Drug by Type
        1.3.1 Overview: Global Central Nervous System (CNS) Drug Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Central Nervous System (CNS) Drug Consumption Value Market Share by Type in 2023
        1.3.3 Prescription Drugs
        1.3.4 OTC
    1.4 Global Central Nervous System (CNS) Drug Market by Application
        1.4.1 Overview: Global Central Nervous System (CNS) Drug Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 MS Therapeutics
        1.4.3 Antipsychotic Drugs
        1.4.4 Depression Drugs
        1.4.5 Epilepsy Drugs
        1.4.6 Others
    1.5 Global Central Nervous System (CNS) Drug Market Size & Forecast
    1.6 Global Central Nervous System (CNS) Drug Market Size and Forecast by Region
        1.6.1 Global Central Nervous System (CNS) Drug Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Central Nervous System (CNS) Drug Market Size by Region, (2019-2030)
        1.6.3 North America Central Nervous System (CNS) Drug Market Size and Prospect (2019-2030)
        1.6.4 Europe Central Nervous System (CNS) Drug Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Central Nervous System (CNS) Drug Market Size and Prospect (2019-2030)
        1.6.6 South America Central Nervous System (CNS) Drug Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Central Nervous System (CNS) Drug Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Johnson & Johnson
        2.1.1 Johnson & Johnson Details
        2.1.2 Johnson & Johnson Major Business
        2.1.3 Johnson & Johnson Central Nervous System (CNS) Drug Product and Solutions
        2.1.4 Johnson & Johnson Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Johnson & Johnson Recent Developments and Future Plans
    2.2 Pfizer Inc
        2.2.1 Pfizer Inc Details
        2.2.2 Pfizer Inc Major Business
        2.2.3 Pfizer Inc Central Nervous System (CNS) Drug Product and Solutions
        2.2.4 Pfizer Inc Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Pfizer Inc Recent Developments and Future Plans
    2.3 Novartis AG
        2.3.1 Novartis AG Details
        2.3.2 Novartis AG Major Business
        2.3.3 Novartis AG Central Nervous System (CNS) Drug Product and Solutions
        2.3.4 Novartis AG Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Novartis AG Recent Developments and Future Plans
    2.4 GSK
        2.4.1 GSK Details
        2.4.2 GSK Major Business
        2.4.3 GSK Central Nervous System (CNS) Drug Product and Solutions
        2.4.4 GSK Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 GSK Recent Developments and Future Plans
    2.5 Eli Lilly
        2.5.1 Eli Lilly Details
        2.5.2 Eli Lilly Major Business
        2.5.3 Eli Lilly Central Nervous System (CNS) Drug Product and Solutions
        2.5.4 Eli Lilly Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Eli Lilly Recent Developments and Future Plans
    2.6 Teva
        2.6.1 Teva Details
        2.6.2 Teva Major Business
        2.6.3 Teva Central Nervous System (CNS) Drug Product and Solutions
        2.6.4 Teva Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Teva Recent Developments and Future Plans
    2.7 Otsuka Pharmaceutical Co., Ltd
        2.7.1 Otsuka Pharmaceutical Co., Ltd Details
        2.7.2 Otsuka Pharmaceutical Co., Ltd Major Business
        2.7.3 Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Product and Solutions
        2.7.4 Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Otsuka Pharmaceutical Co., Ltd Recent Developments and Future Plans
    2.8 Biogen Inc
        2.8.1 Biogen Inc Details
        2.8.2 Biogen Inc Major Business
        2.8.3 Biogen Inc Central Nervous System (CNS) Drug Product and Solutions
        2.8.4 Biogen Inc Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Biogen Inc Recent Developments and Future Plans
    2.9 Boehringer Ingelheim
        2.9.1 Boehringer Ingelheim Details
        2.9.2 Boehringer Ingelheim Major Business
        2.9.3 Boehringer Ingelheim Central Nervous System (CNS) Drug Product and Solutions
        2.9.4 Boehringer Ingelheim Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Boehringer Ingelheim Recent Developments and Future Plans
    2.10 Roche
        2.10.1 Roche Details
        2.10.2 Roche Major Business
        2.10.3 Roche Central Nervous System (CNS) Drug Product and Solutions
        2.10.4 Roche Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Roche Recent Developments and Future Plans
    2.11 UCB
        2.11.1 UCB Details
        2.11.2 UCB Major Business
        2.11.3 UCB Central Nervous System (CNS) Drug Product and Solutions
        2.11.4 UCB Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 UCB Recent Developments and Future Plans
    2.12 Tekeda
        2.12.1 Tekeda Details
        2.12.2 Tekeda Major Business
        2.12.3 Tekeda Central Nervous System (CNS) Drug Product and Solutions
        2.12.4 Tekeda Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Tekeda Recent Developments and Future Plans
    2.13 Shanghai Fosun
        2.13.1 Shanghai Fosun Details
        2.13.2 Shanghai Fosun Major Business
        2.13.3 Shanghai Fosun Central Nervous System (CNS) Drug Product and Solutions
        2.13.4 Shanghai Fosun Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Shanghai Fosun Recent Developments and Future Plans
    2.14 Jiangsu Nhwa Pharmaceutical Co., Ltd.
        2.14.1 Jiangsu Nhwa Pharmaceutical Co., Ltd. Details
        2.14.2 Jiangsu Nhwa Pharmaceutical Co., Ltd. Major Business
        2.14.3 Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Product and Solutions
        2.14.4 Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 Jiangsu Nhwa Pharmaceutical Co., Ltd. Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Central Nervous System (CNS) Drug Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Central Nervous System (CNS) Drug by Company Revenue
        3.2.2 Top 3 Central Nervous System (CNS) Drug Players Market Share in 2023
        3.2.3 Top 6 Central Nervous System (CNS) Drug Players Market Share in 2023
    3.3 Central Nervous System (CNS) Drug Market: Overall Company Footprint Analysis
        3.3.1 Central Nervous System (CNS) Drug Market: Region Footprint
        3.3.2 Central Nervous System (CNS) Drug Market: Company Product Type Footprint
        3.3.3 Central Nervous System (CNS) Drug Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Central Nervous System (CNS) Drug Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Central Nervous System (CNS) Drug Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Central Nervous System (CNS) Drug Consumption Value Market Share by Application (2019-2024)
    5.2 Global Central Nervous System (CNS) Drug Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Central Nervous System (CNS) Drug Consumption Value by Type (2019-2030)
    6.2 North America Central Nervous System (CNS) Drug Consumption Value by Application (2019-2030)
    6.3 North America Central Nervous System (CNS) Drug Market Size by Country
        6.3.1 North America Central Nervous System (CNS) Drug Consumption Value by Country (2019-2030)
        6.3.2 United States Central Nervous System (CNS) Drug Market Size and Forecast (2019-2030)
        6.3.3 Canada Central Nervous System (CNS) Drug Market Size and Forecast (2019-2030)
        6.3.4 Mexico Central Nervous System (CNS) Drug Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Central Nervous System (CNS) Drug Consumption Value by Type (2019-2030)
    7.2 Europe Central Nervous System (CNS) Drug Consumption Value by Application (2019-2030)
    7.3 Europe Central Nervous System (CNS) Drug Market Size by Country
        7.3.1 Europe Central Nervous System (CNS) Drug Consumption Value by Country (2019-2030)
        7.3.2 Germany Central Nervous System (CNS) Drug Market Size and Forecast (2019-2030)
        7.3.3 France Central Nervous System (CNS) Drug Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Central Nervous System (CNS) Drug Market Size and Forecast (2019-2030)
        7.3.5 Russia Central Nervous System (CNS) Drug Market Size and Forecast (2019-2030)
        7.3.6 Italy Central Nervous System (CNS) Drug Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Central Nervous System (CNS) Drug Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Central Nervous System (CNS) Drug Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Central Nervous System (CNS) Drug Market Size by Region
        8.3.1 Asia-Pacific Central Nervous System (CNS) Drug Consumption Value by Region (2019-2030)
        8.3.2 China Central Nervous System (CNS) Drug Market Size and Forecast (2019-2030)
        8.3.3 Japan Central Nervous System (CNS) Drug Market Size and Forecast (2019-2030)
        8.3.4 South Korea Central Nervous System (CNS) Drug Market Size and Forecast (2019-2030)
        8.3.5 India Central Nervous System (CNS) Drug Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Central Nervous System (CNS) Drug Market Size and Forecast (2019-2030)
        8.3.7 Australia Central Nervous System (CNS) Drug Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Central Nervous System (CNS) Drug Consumption Value by Type (2019-2030)
    9.2 South America Central Nervous System (CNS) Drug Consumption Value by Application (2019-2030)
    9.3 South America Central Nervous System (CNS) Drug Market Size by Country
        9.3.1 South America Central Nervous System (CNS) Drug Consumption Value by Country (2019-2030)
        9.3.2 Brazil Central Nervous System (CNS) Drug Market Size and Forecast (2019-2030)
        9.3.3 Argentina Central Nervous System (CNS) Drug Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Central Nervous System (CNS) Drug Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Central Nervous System (CNS) Drug Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country
        10.3.1 Middle East & Africa Central Nervous System (CNS) Drug Consumption Value by Country (2019-2030)
        10.3.2 Turkey Central Nervous System (CNS) Drug Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Central Nervous System (CNS) Drug Market Size and Forecast (2019-2030)
        10.3.4 UAE Central Nervous System (CNS) Drug Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Central Nervous System (CNS) Drug Market Drivers
    11.2 Central Nervous System (CNS) Drug Market Restraints
    11.3 Central Nervous System (CNS) Drug Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Central Nervous System (CNS) Drug Industry Chain
    12.2 Central Nervous System (CNS) Drug Upstream Analysis
    12.3 Central Nervous System (CNS) Drug Midstream Analysis
    12.4 Central Nervous System (CNS) Drug Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Central Nervous System (CNS) Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Central Nervous System (CNS) Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Central Nervous System (CNS) Drug Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Central Nervous System (CNS) Drug Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Johnson & Johnson Company Information, Head Office, and Major Competitors
    Table 6. Johnson & Johnson Major Business
    Table 7. Johnson & Johnson Central Nervous System (CNS) Drug Product and Solutions
    Table 8. Johnson & Johnson Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Johnson & Johnson Recent Developments and Future Plans
    Table 10. Pfizer Inc Company Information, Head Office, and Major Competitors
    Table 11. Pfizer Inc Major Business
    Table 12. Pfizer Inc Central Nervous System (CNS) Drug Product and Solutions
    Table 13. Pfizer Inc Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Pfizer Inc Recent Developments and Future Plans
    Table 15. Novartis AG Company Information, Head Office, and Major Competitors
    Table 16. Novartis AG Major Business
    Table 17. Novartis AG Central Nervous System (CNS) Drug Product and Solutions
    Table 18. Novartis AG Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Novartis AG Recent Developments and Future Plans
    Table 20. GSK Company Information, Head Office, and Major Competitors
    Table 21. GSK Major Business
    Table 22. GSK Central Nervous System (CNS) Drug Product and Solutions
    Table 23. GSK Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. GSK Recent Developments and Future Plans
    Table 25. Eli Lilly Company Information, Head Office, and Major Competitors
    Table 26. Eli Lilly Major Business
    Table 27. Eli Lilly Central Nervous System (CNS) Drug Product and Solutions
    Table 28. Eli Lilly Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Eli Lilly Recent Developments and Future Plans
    Table 30. Teva Company Information, Head Office, and Major Competitors
    Table 31. Teva Major Business
    Table 32. Teva Central Nervous System (CNS) Drug Product and Solutions
    Table 33. Teva Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Teva Recent Developments and Future Plans
    Table 35. Otsuka Pharmaceutical Co., Ltd Company Information, Head Office, and Major Competitors
    Table 36. Otsuka Pharmaceutical Co., Ltd Major Business
    Table 37. Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Product and Solutions
    Table 38. Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Otsuka Pharmaceutical Co., Ltd Recent Developments and Future Plans
    Table 40. Biogen Inc Company Information, Head Office, and Major Competitors
    Table 41. Biogen Inc Major Business
    Table 42. Biogen Inc Central Nervous System (CNS) Drug Product and Solutions
    Table 43. Biogen Inc Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Biogen Inc Recent Developments and Future Plans
    Table 45. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
    Table 46. Boehringer Ingelheim Major Business
    Table 47. Boehringer Ingelheim Central Nervous System (CNS) Drug Product and Solutions
    Table 48. Boehringer Ingelheim Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Boehringer Ingelheim Recent Developments and Future Plans
    Table 50. Roche Company Information, Head Office, and Major Competitors
    Table 51. Roche Major Business
    Table 52. Roche Central Nervous System (CNS) Drug Product and Solutions
    Table 53. Roche Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Roche Recent Developments and Future Plans
    Table 55. UCB Company Information, Head Office, and Major Competitors
    Table 56. UCB Major Business
    Table 57. UCB Central Nervous System (CNS) Drug Product and Solutions
    Table 58. UCB Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 59. UCB Recent Developments and Future Plans
    Table 60. Tekeda Company Information, Head Office, and Major Competitors
    Table 61. Tekeda Major Business
    Table 62. Tekeda Central Nervous System (CNS) Drug Product and Solutions
    Table 63. Tekeda Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 64. Tekeda Recent Developments and Future Plans
    Table 65. Shanghai Fosun Company Information, Head Office, and Major Competitors
    Table 66. Shanghai Fosun Major Business
    Table 67. Shanghai Fosun Central Nervous System (CNS) Drug Product and Solutions
    Table 68. Shanghai Fosun Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 69. Shanghai Fosun Recent Developments and Future Plans
    Table 70. Jiangsu Nhwa Pharmaceutical Co., Ltd. Company Information, Head Office, and Major Competitors
    Table 71. Jiangsu Nhwa Pharmaceutical Co., Ltd. Major Business
    Table 72. Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Product and Solutions
    Table 73. Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 74. Jiangsu Nhwa Pharmaceutical Co., Ltd. Recent Developments and Future Plans
    Table 75. Global Central Nervous System (CNS) Drug Revenue (USD Million) by Players (2019-2024)
    Table 76. Global Central Nervous System (CNS) Drug Revenue Share by Players (2019-2024)
    Table 77. Breakdown of Central Nervous System (CNS) Drug by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 78. Market Position of Players in Central Nervous System (CNS) Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 79. Head Office of Key Central Nervous System (CNS) Drug Players
    Table 80. Central Nervous System (CNS) Drug Market: Company Product Type Footprint
    Table 81. Central Nervous System (CNS) Drug Market: Company Product Application Footprint
    Table 82. Central Nervous System (CNS) Drug New Market Entrants and Barriers to Market Entry
    Table 83. Central Nervous System (CNS) Drug Mergers, Acquisition, Agreements, and Collaborations
    Table 84. Global Central Nervous System (CNS) Drug Consumption Value (USD Million) by Type (2019-2024)
    Table 85. Global Central Nervous System (CNS) Drug Consumption Value Share by Type (2019-2024)
    Table 86. Global Central Nervous System (CNS) Drug Consumption Value Forecast by Type (2025-2030)
    Table 87. Global Central Nervous System (CNS) Drug Consumption Value by Application (2019-2024)
    Table 88. Global Central Nervous System (CNS) Drug Consumption Value Forecast by Application (2025-2030)
    Table 89. North America Central Nervous System (CNS) Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 90. North America Central Nervous System (CNS) Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 91. North America Central Nervous System (CNS) Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 92. North America Central Nervous System (CNS) Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 93. North America Central Nervous System (CNS) Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 94. North America Central Nervous System (CNS) Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 95. Europe Central Nervous System (CNS) Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 96. Europe Central Nervous System (CNS) Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 97. Europe Central Nervous System (CNS) Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 98. Europe Central Nervous System (CNS) Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 99. Europe Central Nervous System (CNS) Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 100. Europe Central Nervous System (CNS) Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 101. Asia-Pacific Central Nervous System (CNS) Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 102. Asia-Pacific Central Nervous System (CNS) Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 103. Asia-Pacific Central Nervous System (CNS) Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 104. Asia-Pacific Central Nervous System (CNS) Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 105. Asia-Pacific Central Nervous System (CNS) Drug Consumption Value by Region (2019-2024) & (USD Million)
    Table 106. Asia-Pacific Central Nervous System (CNS) Drug Consumption Value by Region (2025-2030) & (USD Million)
    Table 107. South America Central Nervous System (CNS) Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 108. South America Central Nervous System (CNS) Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 109. South America Central Nervous System (CNS) Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 110. South America Central Nervous System (CNS) Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 111. South America Central Nervous System (CNS) Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 112. South America Central Nervous System (CNS) Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 113. Middle East & Africa Central Nervous System (CNS) Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 114. Middle East & Africa Central Nervous System (CNS) Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 115. Middle East & Africa Central Nervous System (CNS) Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 116. Middle East & Africa Central Nervous System (CNS) Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 117. Middle East & Africa Central Nervous System (CNS) Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 118. Middle East & Africa Central Nervous System (CNS) Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 119. Central Nervous System (CNS) Drug Raw Material
    Table 120. Key Suppliers of Central Nervous System (CNS) Drug Raw Materials
List of Figures
    Figure 1. Central Nervous System (CNS) Drug Picture
    Figure 2. Global Central Nervous System (CNS) Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Central Nervous System (CNS) Drug Consumption Value Market Share by Type in 2023
    Figure 4. Prescription Drugs
    Figure 5. OTC
    Figure 6. Global Central Nervous System (CNS) Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 7. Central Nervous System (CNS) Drug Consumption Value Market Share by Application in 2023
    Figure 8. MS Therapeutics Picture
    Figure 9. Antipsychotic Drugs Picture
    Figure 10. Depression Drugs Picture
    Figure 11. Epilepsy Drugs Picture
    Figure 12. Others Picture
    Figure 13. Global Central Nervous System (CNS) Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 14. Global Central Nervous System (CNS) Drug Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 15. Global Market Central Nervous System (CNS) Drug Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 16. Global Central Nervous System (CNS) Drug Consumption Value Market Share by Region (2019-2030)
    Figure 17. Global Central Nervous System (CNS) Drug Consumption Value Market Share by Region in 2023
    Figure 18. North America Central Nervous System (CNS) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Central Nervous System (CNS) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 20. Asia-Pacific Central Nervous System (CNS) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 21. South America Central Nervous System (CNS) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 22. Middle East and Africa Central Nervous System (CNS) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 23. Global Central Nervous System (CNS) Drug Revenue Share by Players in 2023
    Figure 24. Central Nervous System (CNS) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 25. Global Top 3 Players Central Nervous System (CNS) Drug Market Share in 2023
    Figure 26. Global Top 6 Players Central Nervous System (CNS) Drug Market Share in 2023
    Figure 27. Global Central Nervous System (CNS) Drug Consumption Value Share by Type (2019-2024)
    Figure 28. Global Central Nervous System (CNS) Drug Market Share Forecast by Type (2025-2030)
    Figure 29. Global Central Nervous System (CNS) Drug Consumption Value Share by Application (2019-2024)
    Figure 30. Global Central Nervous System (CNS) Drug Market Share Forecast by Application (2025-2030)
    Figure 31. North America Central Nervous System (CNS) Drug Consumption Value Market Share by Type (2019-2030)
    Figure 32. North America Central Nervous System (CNS) Drug Consumption Value Market Share by Application (2019-2030)
    Figure 33. North America Central Nervous System (CNS) Drug Consumption Value Market Share by Country (2019-2030)
    Figure 34. United States Central Nervous System (CNS) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 35. Canada Central Nervous System (CNS) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 36. Mexico Central Nervous System (CNS) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 37. Europe Central Nervous System (CNS) Drug Consumption Value Market Share by Type (2019-2030)
    Figure 38. Europe Central Nervous System (CNS) Drug Consumption Value Market Share by Application (2019-2030)
    Figure 39. Europe Central Nervous System (CNS) Drug Consumption Value Market Share by Country (2019-2030)
    Figure 40. Germany Central Nervous System (CNS) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 41. France Central Nervous System (CNS) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 42. United Kingdom Central Nervous System (CNS) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 43. Russia Central Nervous System (CNS) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 44. Italy Central Nervous System (CNS) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 45. Asia-Pacific Central Nervous System (CNS) Drug Consumption Value Market Share by Type (2019-2030)
    Figure 46. Asia-Pacific Central Nervous System (CNS) Drug Consumption Value Market Share by Application (2019-2030)
    Figure 47. Asia-Pacific Central Nervous System (CNS) Drug Consumption Value Market Share by Region (2019-2030)
    Figure 48. China Central Nervous System (CNS) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 49. Japan Central Nervous System (CNS) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 50. South Korea Central Nervous System (CNS) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 51. India Central Nervous System (CNS) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 52. Southeast Asia Central Nervous System (CNS) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 53. Australia Central Nervous System (CNS) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 54. South America Central Nervous System (CNS) Drug Consumption Value Market Share by Type (2019-2030)
    Figure 55. South America Central Nervous System (CNS) Drug Consumption Value Market Share by Application (2019-2030)
    Figure 56. South America Central Nervous System (CNS) Drug Consumption Value Market Share by Country (2019-2030)
    Figure 57. Brazil Central Nervous System (CNS) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 58. Argentina Central Nervous System (CNS) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 59. Middle East and Africa Central Nervous System (CNS) Drug Consumption Value Market Share by Type (2019-2030)
    Figure 60. Middle East and Africa Central Nervous System (CNS) Drug Consumption Value Market Share by Application (2019-2030)
    Figure 61. Middle East and Africa Central Nervous System (CNS) Drug Consumption Value Market Share by Country (2019-2030)
    Figure 62. Turkey Central Nervous System (CNS) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 63. Saudi Arabia Central Nervous System (CNS) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 64. UAE Central Nervous System (CNS) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 65. Central Nervous System (CNS) Drug Market Drivers
    Figure 66. Central Nervous System (CNS) Drug Market Restraints
    Figure 67. Central Nervous System (CNS) Drug Market Trends
    Figure 68. Porters Five Forces Analysis
    Figure 69. Manufacturing Cost Structure Analysis of Central Nervous System (CNS) Drug in 2023
    Figure 70. Manufacturing Process Analysis of Central Nervous System (CNS) Drug
    Figure 71. Central Nervous System (CNS) Drug Industrial Chain
    Figure 72. Methodology
    Figure 73. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Johnson & Johnson
Pfizer Inc
Novartis AG
GSK
Eli Lilly
Teva
Otsuka Pharmaceutical Co., Ltd
Biogen Inc
Boehringer Ingelheim
Roche
UCB
Tekeda
Shanghai Fosun
Jiangsu Nhwa Pharmaceutical Co., Ltd.

Related Reports

Global Central Nervous System (CNS) Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Central Nervous System (CNS) Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 11 Jan 2023

date Pharma & Healthcare

Global Central Nervous System (CNS) Drug Supply, Demand and Key Producers, 2023-2029

Global Central Nervous System (CNS) Drug Supply, Demand and Key Producers, 2023-2029

date 30 Jan 2023

date Pharma & Healthcare

The global Central Nervous System (CNS) Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Central Nervous System (CNS) Drug Supply, Demand and Key Producers, 2024-2030

Global Central Nervous System (CNS) Drug Supply, Demand and Key Producers, 2024-2030

date 09 Feb 2024

date Pharma & Healthcare

The global Central Nervous System (CNS) Drug market size is expected to reach $ 188330 million by 2030, rising at a market growth of 6.7% CAGR during the forecast period (2024-2030).

Product Tags

central nervous system cns drug

Central Nervous System (CNS) Drug

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>